Carglumic acid is a pharmaceutical active ingredient used as a carbamoyl phosphate synthetase 1 activator. It is employed in the management of hyperammonemia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1188-38-1
Norfloxacin nicotinate
pharmaceutical raw material
Tramadol-d6 Hydrochloride
pharmaceutical raw material
2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-[(²H₃)methyloxy]-3,3-diphenylpropanoic acid
pharmaceutical raw material
9-keto risperidone
pharmaceutical raw material
(2S)-2-(carbamoylamino)pentanedioic acid
LCQLHJZYVOQKHU-VKHMYHEASA-N
C(CC(=O)O)[C@@H](C(=O)O)NC(=O)N